Get started
Author

Heli Rajasaar

Observed names: H Rajasaar, Rajasaar, Heli
Institution: University of Tartu
Observed institution: University of Tartu
OpenAlex ID: A5035147979
HIV incidence in the Estonian population in 2013 determined using the HIV ‐1 limiting antigen avidity assay
2017 · P Soodla, R Simmons, et al. · HIV Medicine · 14
PDF
Design and structure of the Estonian HIV Cohort Study (E-HIV)
2015 · Pilleriin Soodla, Heli Rajasaar, et al. · Scandinavian Journal of Infectious Diseases · 12
Transmitted HIV-1 drug resistance in Estonian residents and Ukrainian refugees in 2020 and 2022
2025 · Arina Šablinskaja, Hiie Soeorg, et al. · Journal of Global Antimicrobial Resistance · 4
No transmitted drug resistance to HIV integrase strand-transfer inhibitors after their scale-up in Estonia in 2017
2023 · Arina Šablinskaja, Merit Pauskar, et al. · Journal of Global Antimicrobial Resistance · 4
Dynamics of hepatitis C epidemic among people living with HIV in Estonia based on Estonian HIV cohort study
2021 · Kerstin Kase, Radko Avi, et al. · BMC Infectious Diseases · 3
PDF
Stable level of HIV transmitted drug resistance in Estonia despite significant scale-up of antiretroviral therapy
2019 · Pilleriin Soodla, Kristi Huik, et al. · Infection Genetics and Evolution · 3
PDF
The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx
2019 · Kristi Huik, Pilleriin Soodla, et al. · PLoS ONE · 3
Early Impact of Severe Acute Respiratory Syndrome Coronavirus 2 on Pediatric Clinical Research: A Pan-European and Canadian Snapshot in Time
2021 · Olivier L. Mantha, Florence Flamein, et al. · The Journal of Pediatrics · 2
PDF
Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
2014 · Kristi Huik, Heli Rajasaar, et al. · BMC Infectious Diseases · 1
PDF
Works count: 11
Citation count: 46
H-index: 4
I10-index: 2
Year
Topic
Type